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R104DispatchesAllergy: Airway Epithelial Rac1 Suppresses Allergic
InflammationLoss of Rac1 in airway epithelial cells has demonstrated its participation in the
ingestion of apoptotic cells and, more importantly, has revealed an unexpected
role for Rac1 in maintaining the anti-inflammatory and non-immunogenic
environment of the lung and reducing the intensity of allergic sensitization.Peter M. Henson
and Donna L. Bratton
In metazoa, effete, unwanted or
damaged cells undergo various forms
of programed cell death, including
apoptosis, and are removed from the
body following uptake into phagocytic
cells and subsequent intraphagosomal
digestion. This process is highly
efficient; so much so, that the presence
of apoptotic cells in tissues can often
only be detected if the clearance
process is blocked, such as by
disruption of genes involved in the
uptake process, for example in
Caenorhabditis elegans [1] or mice [2].
There are numerous mechanisms by
which the dying cells are recognized
for clearance, but key amongst them
is the exposure in the outer plasma
membrane of the phospholipid
phosphatidylserine (PS) [3], which is
normally actively maintained on the
inner membrane leaflet. Redundancy is
also evidenced by the many molecules
and receptors that have been shown
to recognize the PS, as well as the
subsequent signaling pathways that
contribute to the eventual uptake of
the apoptotic cell [4]. Importantly,
these receptors and pathways
merge to initiate a highly conserved
uptake mechanism, a form of
stimulated macropinocytosis, that
shows an absolute requirement
for Rac1, a key member of the Rho
family of low molecular weight
GTPases. For simplicity, we term
the process efferocytosis, in part
to distinguish the recognition and
uptake mechanisms from those of
other forms of phagocytosis, such as
those involved in clearance of
pathogens.
A further element of redundancy in
the process is evident from the many
different cell types that can perform
apoptotic cell clearance, not merely theso-called ‘professional’ phagocytes.
For example, in many tissues in
C. elegans it is the neighboring cells
that carry out the ingestion of apoptotic
cells. In mammals, epithelial cells,
fibroblasts and endothelial cells can all
perform this function, though, for the
most part, probably less efficiently than
macrophages and dendritic cells.
A striking example is involution of the
mammary gland after lactation has
ceased, wherein the secretory
glandular epithelial cells undergo
apoptosis and are then rapidly cleared
by the surviving epithelial cells
themselves — a process that in mice
can result in complete resolution of the
glandular epithelium in as little as four
days [5]. An additional critical element
of the removal of cells undergoing
programmed cell death is that the
process is usually quiet, i.e. without
initiation of either inflammatory or
immunological consequences. In part,
this has been ascribed to the release
of immunosuppressive and
inflammosuppressive mediators, such
as transforming growth factor (TGF) b,
interleukin-10 (IL-10) and inhibitory
eicosanoids, from the ingesting cell
and, once again, PS recognition by
the ingesting cell is a major stimulus
for this effect [6].
These observations set the stage for
the new study reported by Juncadella
et al. [7], which initially set out to assess
the ability of epithelial cells lining the
airways of the murine lung to recognize
and remove apoptotic cells, as well as
the consequences of this efferocytosis
in the possible context of an important
human airways disease — asthma.
The technique used to explore these
questions — specific and inducible
knockdown of Rac1 in airway epithelial
cells in the mouse — not only
addressed the issue of efferocytosis
in these cells, but also opened up
a number of additional and moreinteresting activities for Rac1 in the
normal programming and function of
the airway epithelial cells. First, given
the critical role of Rac1 in cytoskeletal
organization, it was of substantial
importance for the investigation
to demonstrate that the epithelium
in vivo was not obviously altered by
Rac1 deletion in the epithelial cells.
Thus, the animals were allowed to
mature for 8 weeks before the deletion
and a substantial series of studies
supported the apparent normality of
epithelial cell numbers, differentiation,
and function, including assays for
junctional integrity, which is critical
for an epithelium that is exposed to
the outside environment of air-borne
particulates and potential allergens.
However, it could be noted that the
permeability assay likely primarily
assessed the alveolar epithelium,
which represents the major surface
area of the lung and whose cells do not
normally express the promoter used
for Rac1 deletion. As the study went
on to show, Rac1 deletion certainly
changed the properties of the airway
epithelium, even if not obviously
altering its overall composition,
structure and barrier function.
In pursuing the first objective, the
authors confirmed previous studies
(for example [8,9]) and demonstrated
that airway epithelial cells did show
evidence of apoptotic cell uptake
in vitro and, following instillation of
apoptotic cells into the murine airways,
in vivo, that such uptake was
dependent on PS exposure and,
importantly herein, was prevented
by selective knockdown of Rac1 in
the airway epithelium. Nonetheless,
although not altering the overall
implications of the ‘apoptotic cell’
uptake observations made in this
investigation, it is not clear, especially
in vivo, what was actually ingested.
The FACS-based assay used in this
study cannot distinguish between
uptake of intact apoptotic cells versus
membrane-bound cell fragments or
apoptotic bodies. Additionally, whether
the airway epithelial cells constitute
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Figure 1. Interaction of PS-exposing apoptotic cells with airway epithelial cells.
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Figure 2. Possible role for Rac1 in airway
epithelial cells for maintaining or enhancing
the anti-allergenic environment in the lung.
The Rac:Rho balance is also illustrated and
provides a possible point for intervention.
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R105an important clearance mechanism
for dying cells within the lumen of the
lung might be questioned: alveolar
epithelium (greater surface area),
alveolar macrophages (greater
efferocytic activity) and the airway
mucociliary escalator driven by the
ciliated epithelial cells all likely
play important, even dominant,
roles in this effect.
The importance of the Juncadella
et al. [7] study goes substantially
beyond the actual uptake of apoptotic
cells or fragments, however. As clearly
demonstrated, both in vitro and in vivo,
Rac1 expression in the airway epithelial
cells was required for their production
of IL-10 and TGFb in response to the
apoptotic cells. Thus, after Rac1
deletion, the levels of suppressive
cytokines were reduced. While at first
glance these effects of Rac1 deletion
might be attributed to reduced uptake
of apoptotic cells, studies in other
systems show that actual ingestion
of the apoptotic cell or fragment/
microparticles is not necessary for
the production of anti-inflammatory
mediators. As expected, however, the
production of these anti-inflammatory
mediators by airway epithelial cells as
shown in this study was dependent on
PS. Additionally, it is not yet clear which
airway epithelial cell was responsible;
the murine airway barrier epithelium
comprises both a ciliated and secretory
cell form, with the secretory cell morelikely to be deleted of Rac1 in this
experimental system, and both
appeared to be present normally after
the deletion (Figure 1). To add to the
complexity, the Rho family GTPases do
not act independently and there is
substantial evidence that Rac and Rho
function competitively [10,11]
(Figure 2). Accordingly, an intriguing
line of further investigation would be to
assess the precise role of diminished
Rac activity versus an expected
enhanced effect of Rho within the
epithelial cells.
Thus, it is in this context that
Juncadella et al. [7] tell an even more
compelling second story where
epithelial Rac1 appears to play
a significant role in maintaining
the normal non-inflammatory,
anti-immunogenic (anti-allergenic)
environment in the lung. Investigating
a commonly used murine
hypersensitivity model of human
allergic asthma, the absence of airway
epithelial Rac1 resulted in heightened
immunological and inflammatory
responses in a two-step model of
airway sensitization with allergen
(priming) followed by later inhalational
challenge with the allergen to induce
allergic inflammation and heightened
bronchoconstriction. Following the
challenge with dust mite allergen,
animals deficient in airway epithelial
Rac1 showed increases in
lung-infiltrating T lymphocytes andeosinophils, allergic cytokine
production by draining lymph node
T cells, serum immunoglobulin E levels,
mucus production, airway resistance
and hyper-responsiveness. Production
of IL-33, a pro-allergenic cytokine of
substantial current interest, was also
enhanced in the absence of Rac1.
Importantly, IL-10 was diminished in
lung lavage of these animals and this
finding proved to be pivotal, in that
IL-10 replenishment reversed the
heightened allergenic responses. By
phased timing of the induction of Rac1
deletion, the effect of epithelial Rac1
was shown to act at the sensitization
rather than the challenge step. It is also
noteworthy that, in the absence of
Rac1, allergen priming via the airway
was much more effective, and even
inhalation of an antigen not normally
able to sensitize the mice was now able
to prime for subsequent allergic
challenge.
What is not clear, however, is
whether the observed effects of
responses to apoptotic cells (or their
uptake) play any role in the allergenic
effects. The observations do clearly
support a normally dampening effect
of the epithelial Rac1 GTPase, point
to its action in this model as
anti-immunogenic at the sensitization
step (which is critically required for
the induction of significant allergic
inflammation), and raise intriguing
questions about its role in normally
preventing sensitization for human
asthma. An intriguing implication here,
is that altering the functional Rho:Rac
effects in vivo, for efferocytosis as
well as anti-inflammatory mediator
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For instance, this balance can be
tipped towards Rac effects by statin
drugs [12] acting through their
somewhat more selective inhibition
of Rho activation. If so, perhaps
statins could decrease the
sensitization phase in the murine
hypersensitivity model employed
here, and perhaps even in some
circumstances in human asthma.
While therapeutics for allergic asthma,
particularly inhaled corticosteroids,
are largely effective in treating
established disease, none currently
targets the initial sensitization steps.
Thus, enhancing airway epithelial
Rac may be a novel target in early
intervention, or even prevention, of this
disease.
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to Hide Your EggsA new study of camouflage in quail shows that individual birds know the
appearance of their own eggs and select backgrounds that maximise
concealment.Martin Stevens
The study of camouflage has been
a central feature of evolutionary theory
since Darwin and Wallace [1,2],
exemplified by the classic textbook
example of evolution: the peppered
moth [3,4]. As a phenomenon,
camouflage seems intuitively
simple — one only needs to find
a hidden stick insect or cuttlefish to
appreciate its function. Only in the last
decade, however, have scientists really
got to grips with the different forms of
camouflage that exist, tested the
survival value that they confer, and how
they work in terms of visual processing.
In this time, the first experimental
support has been found for almost all
types of camouflage [5–7], despite
most theories existing for more than
100 years [8]. The emphasis in most
research has been on the optimizationand tuning of camouflage coloration
over successive generations, yet it is
well known that individuals of various
species, for example many moths,
show species-level behavioural
preferences for particular backgrounds
to rest on [9,10]. But little work has
tested whether individuals within
a species actively chose backgrounds
or microhabitats that best confer
camouflage with regards to their own
specific appearance. In this issue of
Current Biology, Lovell et al. [11] report
that individual Japanese quail (Coturnix
japonica), when given a choice of
substrates of different colours, select
the background to lay their eggs on
that confers the best camouflage.
Lovell et al.’s [11] experiment
showed that the individual quail
choices were dependent on the
appearance of their own eggs,
specifically how maculated (patterned)they are. Individuals with eggs having
lots of dark maculation (up to around
50% of the egg surface) selected
backgrounds that were dark, and this
provided improved concealment
through disruptive coloration (breaking
up the appearance of body outlines
[1,12]) as the dark markings blended
into the backgroundand broke up the
egg shape. Conversely, individuals
with few markings and generally light
coloured eggs chose light coloured
backgrounds that provided
camouflage by background matching
(simply matching the colour and
pattern of the substrate). This new
study has a number of important
implications. First, effective
camouflage can be a product not just
of tuning of appearance over multiple
generations, but also the behavioural
choices of individual animals. A study
of camouflage that simply compares
all individuals to randomly chosen
background samples could be
inappropriate if different individuals
show preferences for specific
microhabitats that optimize their own
concealment. This could be especially
important in highly mobile species.
A next step in this area of work is to
test what specific cues individuals
